Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TREVENA INC | 344,022 | reported | 10 Feb 2021 | tx 5+737,950−21,178 |
| MEDGENICS, INC. | 100,000 | reported | 15 Apr 2016 | tx 3+556,098 |
| Cingulate Inc. | 15,000 | reported | 15 Jun 2023 | tx 2+27,000 |
| Vitae Pharmaceuticals, Inc | 0 | reported | 25 Oct 2016 | tx 2+150,000−150,000 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Jun 2023 | GRANT_AWARD | Cingulate Inc. | 15,000 | 0.00 USD | deriv |
| 09 Aug 2022 | GRANT_AWARD | Cingulate Inc. | 12,000 | 0.00 USD | deriv |
| 10 Feb 2021 | TAX_WITHHOLDING | TREVENA INC | 21,178 | 2.85 USD | |
| 17 Dec 2020 | GRANT_AWARD | TREVENA INC | 115,200 | 0.00 USD | |
| 17 Dec 2020 | GRANT_AWARD | TREVENA INC | 172,750 | 0.00 USD | deriv |
| 10 Feb 2020 | GRANT_AWARD | TREVENA INC | 250,000 | 0.00 USD | |
| 10 Feb 2020 | GRANT_AWARD | TREVENA INC | 200,000 | 0.00 USD | deriv |
| 25 Oct 2016 | OTHER | Vitae Pharmaceuticals, Inc | 150,000 | 12.25 USD | deriv |
| 10 Aug 2016 | GRANT_AWARD | Vitae Pharmaceuticals, Inc | 150,000 | 0.00 USD | deriv |
| 15 Apr 2016 | GRANT_AWARD | MEDGENICS, INC. | 100,000 | 0.00 USD | deriv |
| 01 Dec 2014 | PURCHASE | MEDGENICS, INC. | 6,098 | 4.10 USD | |
| 08 Sept 2014 | GRANT_AWARD | MEDGENICS, INC. | 450,000 | 0.00 USD | deriv |